Young N.Hematologic and hematopoietic consequences of B 19 parvovirus infection . Semin Hematol.1988;25:159-172.
2.
Serjeant GR, Mason K., Topley JM, et al. Outbreak of aplastic crises in sickle cell anemia associated with parvovirus-like agent. Lancet. 1981;2:595-597.
Rappaport ES , Quick G., Ransom D., et al. Aplastic crisis in occult hereditary spherocytosis caused by human parvovirus (HPV B19). South Med J.1989;82:247-251.
5.
Koch WC, Massey G., Russell CE, Adler SPManifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr.1990 ;116:355-359.
6.
Kurtzman GJ, Meyers P., Cohen B., et al. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet . 1988;ii:1159-1162.
7.
Frickhofen N. , Raghavachar A., Heit W., Heimpel H.Human parvovirus infection. N Engl Med.1986;310:646.
8.
Young N., Mortimer P.Viruses and bone marrow failure. Blood.1984 ;63:729-737.
9.
Kurtzman GJ, Gascon P., Caras M., et al. B19 parvovirus replicates in circulating cells of acutely infected patients. Blood.1988;71:1448-1454.
10.
Kurtzman GJ , Ozawa K., Cohen B., et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med.1987 ;317:287-294.